-
Venetoclax in combination with chemotherapy as treatment for pediatric advanced hematologic malignancies. Pediatr Blood Cancer. 2023 06; 70(6):e30335.
Marinoff AE, Aaronson K, Agrawal AK, Braun BS, Golden C, Huang BJ, Michlitsch J, Southworth E, Thrall A, Vo KT, Stieglitz E. PMID: 37036306; PMCID: PMC10133180.
View in:
PubMed Mentions: Fields:
Translation:
Humans
-
Patterns of Locoregional Relapse after Radiotherapy for High-Risk Neuroblastoma: A Multi-Institutional Study. International Journal of Radiation Oncology • Biology • Physics. 2022 Nov 1; 114(3):e488.
Liu LK, Shaaban SS, Lerman LB, Chen CJ, Bagatell BR, Dubois DS, Shusterman SS, Ioakeim-Ioannidou IM, Yock YT, Dusenbery DK, Vo VK, Huang HM, Friedmann FA, Diller DL, Marcus MK, MacDonald MS, Terezakis TS, Braunstein BS, Hill-Kayser HC, Haas-Kogan HD. .
View in:
Publisher Site Mentions:
-
Ulixertinib in patients with tumors with MAPK pathway alterations: Results from NCI-COG Pediatric MATCH trial Arm J (APEC1621J). Journal of Clinical Oncology. 2022 Jun 1; 40(16_suppl):3009-3009.
Vo VK, Sabnis SA, Williams WP, Roy-Chowdhuri RS, Patton PD, Coffey CB, Reid RJ, Piao PJ, Saguilig SL, Alonzo AT, Berg BS, Jaju JA, Fox FE, Hawkins HD, Mooney MM, Takebe TN, Tricoli TJ, Janeway JK, Seibel SN, Parsons PD. .
View in:
Publisher Site Mentions:
-
Clinical and biologic predictors of response to MIBG therapy: A report from the new approaches to neuroblastoma therapy (NANT) consortium. Journal of Clinical Oncology. 2022 Jun 1; 40(16_suppl):e22003-e22003.
Vo VK, Matthay MK, Groshen GS, Chi CY, Granger GM, Park PJ, Marachelian MA, DuBois DS. .
View in:
Publisher Site Mentions:
-
Phase 1/2 study of elraglusib (9-ING-41), a small molecule selective glycogen synthase kinase-3 beta (GSK-3ß) inhibitor, alone or with irinotecan, temozolomide/irinotecan or cyclophosphamide/topotecan in pediatric patients with refractory malignancies: Interim results. Journal of Clinical Oncology. 2022 Jun 1; 40(16_suppl):e22015-e22015.
DeNardo DB, Foster FJ, Pinto PN, Saulnier Sholler SG, Vo VK, Desai DA, Sun SJ, Wagner WL, Macy MM, Mody MR, Oesterheld OJ, Cash CT, Bhuta BR, Barbieri BE, Pearson PA, Cavalcante CL, Giles GF, Lulla LR. .
View in:
Publisher Site Mentions:
-
Incorporating Radiomics into Machine Learning Models to Predict Outcomes of Neuroblastoma. J Digit Imaging. 2022 06; 35(3):605-612.
Liu G, Poon M, Zapala MA, Temple WC, Vo KT, Matthay KK, Mitra D, Seo Y. PMID: 35237892; PMCID: PMC9156639.
View in:
PubMed Mentions:
6 Fields:
Translation:
Humans
-
Pattern and predictors of sites of relapse in neuroblastoma: A report from the International Neuroblastoma Risk Group (INRG) project. Pediatr Blood Cancer. 2022 09; 69(9):e29616.
Vo KT, DuBois SG, Neuhaus J, Braunstein SE, Weil BR, Naranjo A, Irtan S, Balaguer J, Matthay KK. PMID: 35188340; PMCID: PMC9329207.
View in:
PubMed Mentions:
1 Fields:
Translation:
Humans
-
A Comprehensive Circulating Tumor DNA Assay for Detection of Translocation and Copy-Number Changes in Pediatric Sarcomas. Mol Cancer Ther. 2021 10; 20(10):2016-2025.
Shah AT, Azad TD, Breese MR, Chabon JJ, Hamilton EG, Straessler K, Kurtz DM, Leung SG, Spillinger A, Liu HY, Behroozfard IH, Wittber FM, Hazard FK, Cho SJ, Daldrup-Link HE, Vo KT, Rangaswami A, Pribnow A, Spunt SL, Lacayo NJ, Diehn M, Alizadeh AA, Sweet-Cordero EA. PMID: 34353895; PMCID: PMC9307079.
View in:
PubMed Mentions:
9 Fields:
Translation:
Humans
-
Randomized Phase II Trial of MIBG Versus MIBG, Vincristine, and Irinotecan Versus MIBG and Vorinostat for Patients With Relapsed or Refractory Neuroblastoma: A Report From NANT Consortium. J Clin Oncol. 2021 11 01; 39(31):3506-3514.
DuBois SG, Granger MM, Groshen S, Tsao-Wei D, Ji L, Shamirian A, Czarnecki S, Goodarzian F, Berkovich R, Shimada H, Villablanca JG, Vo KT, Pinto N, Mosse YP, Maris JM, Shusterman S, Cohn SL, Goldsmith KC, Weiss B, Yanik GA, Twist CJ, Irwin MS, Haas-Kogan DA, Park JR, Marachelian A, Matthay KK. PMID: 34270348; PMCID: PMC8547934.
View in:
PubMed Mentions:
14 Fields:
Translation:
HumansCTClinical Trials
-
Association of image-defined risk factors with clinical features, histopathology, and outcomes in neuroblastoma. Cancer Med. 2021 04; 10(7):2232-2241.
Temple WC, Vo KT, Matthay KK, Balliu B, Coleman C, Michlitsch J, Phelps A, Behr S, Zapala MA. PMID: 33314708; PMCID: PMC7982630.
View in:
PubMed Mentions:
10 Fields:
Translation:
Humans
-
124I-MIBG PET/CT to Monitor Metastatic Disease in Children with Relapsed Neuroblastoma. J Nucl Med. 2021 01; 62(1):43-47.
Aboian MS, Huang SY, Hernandez-Pampaloni M, Hawkins RA, VanBrocklin HF, Huh Y, Vo KT, Gustafson WC, Matthay KK, Seo Y. PMID: 32414950; PMCID: PMC9364877.
View in:
PubMed Mentions:
9 Fields:
Translation:
Humans
-
Precision Medicine in Pediatric Oncology. Surg Oncol Clin N Am. 2020 01; 29(1):63-72.
Vo KT, Parsons DW, Seibel NL. PMID: 31757314; PMCID: PMC7819485.
View in:
PubMed Mentions:
12 Fields:
Translation:
Humans
-
Abstract CT112: A Phase I multicenter trial of the dual MDM2/MDMX inhibitor ALRN-6924 in children and young adults with relapsed/refractory pediatric cancers. Clinical Trials. 2019 Jul 1; ct112-ct112.
Shulman SD, Vo VK, Fox FE, Muscal MJ, Walensky WL, Pikman PY, Stegmaier SK, Church CA, Crompton CB, Place PA, Chi CS, O'Neill OA, Kamihara KJ, Ezrre ES, Carlowicz CC, Pinchasik PD, Al-Sayegh AH, Ma MC, London LW, DuBois DS. .
View in:
Publisher Site Mentions:
-
Risk Factors for Transplant-Associated Thrombotic Microangiopathy after Autologous Hematopoietic Cell Transplant in High-Risk Neuroblastoma. Biol Blood Marrow Transplant. 2019 10; 25(10):2031-2039.
Tolbert VP, Dvorak CC, Golden C, Vissa M, El-Haj N, Perwad F, Matthay KK, Vo KT. PMID: 31199983; PMCID: PMC9161973.
View in:
PubMed Mentions:
4 Fields:
Translation:
Humans
-
Technical Note: Simplified and practical pretherapy tumor dosimetry - A feasibility study for 131 I-MIBG therapy of neuroblastoma using 124 I-MIBG PET/CT. Med Phys. 2019 May; 46(5):2477-2486.
Seo Y, Huh Y, Huang SY, Hernandez-Pampaloni JM, Hawkins RA, Gustafson WC, Vo KT, Matthay KK. PMID: 30761545; PMCID: PMC6510622.
View in:
PubMed Mentions:
3 Fields:
Translation:
Humans
-
Detection of circulating tumour DNA is associated with inferior outcomes in Ewing sarcoma and osteosarcoma: a report from the Children's Oncology Group. Br J Cancer. 2018 08; 119(5):615-621.
Shulman DS, Klega K, Imamovic-Tuco A, Clapp A, Nag A, Thorner AR, Van Allen E, Ha G, Lessnick SL, Gorlick R, Janeway KA, Leavey PJ, Mascarenhas L, London WB, Vo KT, Stegmaier K, Hall D, Krailo MD, Barkauskas DA, DuBois SG, Crompton BD. PMID: 30131550; PMCID: PMC6162271.
View in:
PubMed Mentions:
48 Fields:
Translation:
Humans
-
Phase 1 study of sirolimus in combination with oral cyclophosphamide and topotecan in children and young adults with relapsed and refractory solid tumors. Oncotarget. 2017 Apr 04; 8(14):23851-23861.
Vo KT, Karski EE, Nasholm NM, Allen S, Hollinger F, Gustafson WC, Long-Boyle JR, Shiboski S, Matthay KK, DuBois SG. PMID: 27793021; PMCID: PMC5410349.
View in:
PubMed Mentions:
7 Fields:
Translation:
HumansCTClinical Trials
-
Incidence and risk factors for secondary malignancy in patients with neuroblastoma after treatment with (131)I-metaiodobenzylguanidine. Eur J Cancer. 2016 10; 66:144-52.
Huibregtse KE, Vo KT, DuBois SG, Fetzko S, Neuhaus J, Batra V, Maris JM, Weiss B, Marachelian A, Yanik GA, Matthay KK. PMID: 27573428; PMCID: PMC7523915.
View in:
PubMed Mentions:
8 Fields:
Translation:
HumansCTClinical Trials
-
Targeted antiangiogenic agents in combination with cytotoxic chemotherapy in preclinical and clinical studies in sarcoma. Clin Sarcoma Res. 2016; 6:9.
Vo KT, Matthay KK, DuBois SG. PMID: 27274393; PMCID: PMC4896001.
View in:
PubMed Mentions:
5
-
Conditional Survival and Predictors of Late Death in Patients With Ewing Sarcoma. Pediatr Blood Cancer. 2016 Jun; 63(6):1091-5.
Davenport JR, Vo KT, Goldsby R, West DC, DuBois SG. PMID: 26891183.
View in:
PubMed Mentions:
8 Fields:
Translation:
Humans
-
Impact of Two Measures of Micrometastatic Disease on Clinical Outcomes in Patients with Newly Diagnosed Ewing Sarcoma: A Report from the Children's Oncology Group. Clin Cancer Res. 2016 07 15; 22(14):3643-50.
Vo KT, Edwards JV, Epling CL, Sinclair E, Hawkins DS, Grier HE, Janeway KA, Barnette P, McIlvaine E, Krailo MD, Barkauskas DA, Matthay KK, Womer RB, Gorlick RG, Lessnick SL, Mackall CL, DuBois SG. PMID: 26861456; PMCID: PMC4947459.
View in:
PubMed Mentions:
12 Fields:
Translation:
Humans
-
Identification of patient subgroups with markedly disparate rates of MYCN amplification in neuroblastoma: A report from the International Neuroblastoma Risk Group project. Cancer. 2016 Mar 15; 122(6):935-45.
Thompson D, Vo KT, London WB, Fischer M, Ambros PF, Nakagawara A, Brodeur GM, Matthay KK, DuBois SG. PMID: 26709890; PMCID: PMC4777644.
View in:
PubMed Mentions:
30 Fields:
Translation:
Humans
-
Clinical, biologic, and prognostic differences on the basis of primary tumor site in neuroblastoma: a report from the international neuroblastoma risk group project. J Clin Oncol. 2014 Oct 01; 32(28):3169-76.
Vo KT, Matthay KK, Neuhaus J, London WB, Hero B, Ambros PF, Nakagawara A, Miniati D, Wheeler K, Pearson AD, Cohn SL, DuBois SG. PMID: 25154816; PMCID: PMC4171360.
View in:
PubMed Mentions:
70 Fields:
Translation:
Humans
-
Menstrual bleeding patterns and prevalence of bleeding disorders in a multidisciplinary adolescent haematology clinic. Haemophilia. 2013 Jan; 19(1):71-5.
Vo KT, Grooms L, Klima J, Holland-Hall C, O'Brien SH. PMID: 23005346.
View in:
PubMed Mentions:
10 Fields:
Translation:
Humans